Latest Pathfinder Cell Therapy Inc (PFND) Headline
Post# of 4
Posted On: 03/10/2014 11:45:44 PM
Latest Pathfinder Cell Therapy Inc (PFND) Headlines
Pathfinder Cells Stimulate Improved Kidney Function and Facilitate Repair of Kidney Tissue Damage Following Acute Kidney Injury
PR Newswire - Tue Apr 02, 7:09AM CDT
Pathfinder Cell Therapy, Inc. ("Pathfinder") (OTCQB: PFND), a biotechnology company focused on the treatment of diseases characterized by organ-specific cell damage, today announced publication of groundbreaking preclinical data demonstrating that the Company's unique cell-based therapy is able to regenerate and enable functional repair of damaged tissue even when extracted from a different species and tissue type. The results of the study, which examined ischemia reperfusion (I/R) injury in a mouse model of renal damage, are currently featured in the February 2013 issue of Rejuvenation Research (Vol. 16, Issue. 1) and available online.
Pathfinder Cells Stimulate Improved Kidney Function and Facilitate Repair of Kidney Tissue Damage Following Acute Kidney Injury
PR Newswire - Tue Apr 02, 7:09AM CDT
Pathfinder Cell Therapy, Inc. ("Pathfinder") (OTCQB: PFND), a biotechnology company focused on the treatment of diseases characterized by organ-specific cell damage, today announced publication of groundbreaking preclinical data demonstrating that the Company's unique cell-based therapy is able to regenerate and enable functional repair of damaged tissue even when extracted from a different species and tissue type. The results of the study, which examined ischemia reperfusion (I/R) injury in a mouse model of renal damage, are currently featured in the February 2013 issue of Rejuvenation Research (Vol. 16, Issue. 1) and available online.
(0)
(0)Pathfinder Cell Therapy, Inc. (PFND) Stock Research Links
Scroll down for more posts ▼